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In this study, we show that CD25hiTNFR2+ cells can be rapidly generated in vitro from cir-
culating CD4 lymphocytes by polyclonal stimuli anti-CD3 in the presence of anti-CD28.The
in vitro induced CD25hiTNFR2+ T cells express a conventional regulatoryT cells phenotype
FOXP3+CTLA4+CD127lo/−, but produce effector and immunoregulatory cytokines includ-
ing IL-2, IL-10, and IFN-g. These induced CD25hiTNFR2+ T cells do not suppress target cell
proliferation, but enhance it instead. Thus the CD25hiTNFR2+ phenotype induced rapidly
following CD3/28 cross linking of CD4T cells identifies cells with maximal proliferative and
effector cytokine-producing capability. The in vivo counterpart of this cell population may
play an important role in immune response initiation.
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INTRODUCTION
Regulatory T cells (Tregs) play a central role in the maintenance
of peripheral tolerance and immune homeostasis, thereby pre-
venting autoimmune diseases (1–3). FOXP3 is a key transcription
factor for Tregs (4–6), with ectopic expression of FOXP3 in human
CD4+ T cells resulting in the acquisition of suppressive function
and down-regulation of effector cytokine production like IFN-g
(4, 5, 7). Although all murine FOXP3+ T cells are regulatory in
function, the definition of human Tregs using FOXP3 is compli-
cated by the fact that effector T cells up-regulate FOXP3 expression
upon activation (8). FOXP3 expression on activated effector T
cells has however been reported to be transient and relatively low
when compared to Tregs (9). Such low levels are believed to be
insufficient to negatively regulate effector cytokine production,
particularly IFN-g (8). This suggests that T cells that are FOXP3hi
are regulatory in function. However, FOXP3 is an intracellular
transcription factor and functional assays cannot be performed
based on FOXP3 expression in human T cells. Hence, a surro-
gate marker that is expressed on the surface of Tregs is required to
distinguish bona fide Tregs.
Recent studies have identified a subset within both murine
and human Tregs that expresses the type II receptor for the
major pro-inflammatory cytokine tumor necrosis factor TNF,
TNFR2 (1, 10, 11). As well as providing a potential link between
the regulation of inflammation and adaptive immunity, ex vivo
TNFR2+ Tregs are maximally suppressive regulators in both mice
and humans, consistent with their higher expression of CTLA4
and FOXP3 (12–14). Additionally, intracellular FOXP3 expression
appeared to positively correlate with surface TNFR2 expression
on human CD4 T cells (1). However, similar to FOXP3 expres-
sion, both murine and human effector T cells also up-regulate
TNFR2 expression upon activation via the T cell receptor (TCR)
(15, 16). A recent murine study demonstrates FOXP3−TNFR2+
effector T cells secrete significantly higher levels of Th1 cytokines
like IFN-g when compared to FOXP3−TNFR2− effector T cells
(17). These effector T cells, however, are in turn susceptible to
suppression exerted by TNFR2+FOXP3+ Tregs (17). The above
data suggest that TNFR2 expression identifies the maximally
functional effector T cells (CD25intTNFR2+FOXP3int) and Tregs
(CD25hiTNFR2+FOXP3hi) in humans. We hypothesized that
human CD25hi T cells expressing TNFR2 identifies Tregs and
TNFR2 may be a surrogate marker for FOXP3.
Herein we show that although human CD25hiTNFR2+FOXP3hi
T cells with a Treg phenotype are inducible in vitro from isolated
CD4 T cells by stimulation via the TCR, these induced cells fail
to suppress proliferation of effector cells, and are surprisingly
the maximally effector cytokine-producing population, capable
of augmenting early proliferative responses.
MATERIALS AND METHODS
CELL ISOLATION
Peripheral blood mononuclear cells (PBMCs) were isolated from
buffy coats of healthy individuals, provided by the Australian Red
Cross Blood Service. CD4+ T cells were isolated from PBMCs
using the CD4 T cell negative isolation kit and LD columns accord-
ing to manufacture’s recommendations (Miltenyi Biotec). The
purified fraction consistently contained 94–99% CD3+CD4+ T
cells by flow cytometry. CD4+CD25− and CD4+CD25+ cells were
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obtained by staining CD4 cells with anti-CD25 PE antibody and
anti-PE magnetic cell isolation beads as per manufacture’s protocol
(BD Pharmingen).
IN VITRO INDUCTION OF CD25HITNFR2+ CELLS
To obtain the induced TNFR2+ T cell subsets, the MACS puri-
fied T cell populations, either un-fractionated CD4+ T cells, or its
sub-populations,CD4+CD25− and CD4+CD25+ T cells were cul-
tured. The T cells were suspended in AIM V medium (Invitrogen)
containing 5% heat inactivated normal human serum (Sigma).
The cells were added (5× 106 cells/2 mL/well) to 24 well plates,
pre-coated with anti-CD3 antibody (2.5µg/mL; OKT3, Biole-
gend). This was followed by the addition of soluble anti-CD28
antibody (1.25µg/mL; CD28.2, BD Pharmingen), and the cells
were cultured for 72 h at 37°C with 5% CO2.
CELL SORTING
The above un-fractionated CD4+ T cell culture was harvested on
day 3, and sorted using a FACS ARIA (Becton Dickinson) to isolate
the CD25hiTNFR2+, CD25intTNFR2int/− and CD25−TNFR2− T
cell populations.
FLOW CYTOMETRY
The following monoclonal antibodies were used for flow cytome-
try analysis: TNFR2 FITC (R&D systems), CD3 FITC/APC, CD4
APC-Cy7, CD25 PE/PeCy7, CD127 bio-PerCP, CTLA4 APC (BD
Pharmingen), and FOXP3 APC/PerCP. Intracellular staining was
performed by firstly using the FOXP3 fixation/permeabilization
kit (eBioscience) followed by staining the cells intracellular using
the FOXP3 antibody. Flow cytometry was performed using BD
LSRII, and data were analyzed using FlowJo software (Treestar).
For intracellular cytokine staining, the MACS isolated total
CD4+ T cells were cultured for 3 days, stimulating with CD3/28.
On day 3, PMA (50 ng/mL) and Ionomycin (1 mg/mL) were added
for 5 h, with Brefeldin A (ebioscience) supplementation for the
final 4 h. After stimulation, the cells were stained with intracellular
IFN-γ, IL-2, and FOXP3 staining. Flow cytometry was performed
using BD ARIA, and data were analyzed using FlowJo.
SUPPRESSION ASSAYS
For suppression assays, the sorted cells above were irradiated at
40 Gy for use as suppressors. The responder cells consisted of
cryopreserved autologous CD4+ T cells that are defrosted and
washed. The sorted cell subsets, re-suspended at 105 cells/50µl in
AIM V media containing 5% human serum, were mixed with an
equal number of the responder cells. The mixture was then added
to a 96 U bottom plate (Becton Dickinson) and stimulated for a
further 72 h using CD3/28 stimulation as above. On day 3, cells
were pulsed overnight at 37°C with 5µCi/mL per well of TRK
120 titrated thymidine (Amersham, UK). Cells were then har-
vested and proliferation was determined by thymidine incorpo-
ration, measured by a liquid scintillation counter, Topcount NXT
(Packard, USA). In some experiments, autologous CD4 depleted
(using anti-CD4 microbeads, Miltenyi Biotec) PBMCs were irra-
diated at 40 Gy, and used as antigen presenting cells. A mixed
lymphocyte reaction (MLR) was also used as responders, where
PBMCs of three different donors were cultured together.
PROLIFERATION ASSAY AND CYTOKINE BEADS ARRAY
For proliferation assays, the sorted CD25hiTNFR2+,
CD25intTNFR2int/− and CD25−TNFR2− cells was re-stimulated
for 3 days using CD3/28, pulsed with titrated thymidine on day 3
and analyzed as above. Supernatant was removed prior to thymi-
dine addition for cytokine analysis, where the cytokines present
in the supernatant were determined using CBA-flex kits (BD
Pharmingen) as per the manufacture’s protocol, and data analyzed
using the manufacture’s software.
RNA ISOLATION AND REAL TIME RT-PCR
Total RNA was isolated from a minimum of 105 cells of each of
the sorted TNFR2 subsets using the RNA isolation kit (Roche,
Germany). The first-strand cDNA was synthesized using oligo-
dT primers and Superscript II reverse transcriptase (Invitrogen).
qPCR for IL-10, TGF-b, IFN-g, T-bet FOXP3, and house keep-
ing control 18SrRNA was performed using commercial primers
and SYBR green reagent (Life technologies). PCR was performed
using an ABI PRISM 7900 (Applied Biosystems). Results for target
genes were normalized to 18SrRNA expression and expressed as
fold changes between TNFR2 subsets.
STATISTICAL ANALYSIS
To compare between the induced TNFR2 subsets, one-way
ANOVA with Tukey’s multiple comparison test was used if data
were normally distributed and Kruskal–Wallis test with Dunn’s
multiple comparison test was used if the data were not normally
distributed (Graphpad 5.0).
RESULTS
CD25HITNFR2+T CELLS INDUCED UPON IN VITRO STIMULATION OF CD4
T CELLS VIA THE TCR HAVE A CONVENTIONAL TREG PHENOTYPE
TNFR2 expression on Tregs is believed to be critical for Treg func-
tion (12). It is unknown however, if functional TNFR2+ Tregs
can be rapidly generated in vivo from circulating human periph-
eral blood CD4 lymphocytes during an active immune response.
To address this question using an in vitro model, we purified
CD4+CD25− T cells and CD4+CD25+ T cells and stimulated the
cells using anti-CD3 in the presence of CD28 to provide the sec-
ondary signal. After 72 h, these in vitro stimulated T cells could be
differentiated into distinct CD25−TNFR2−, CD25intTNFR2int/−,
and CD25hiTNFR2+ T cells sub-populations (Figure 1A). While
substantial numbers of CD25hiTNFR2+ T cells were induced from
the CD4+CD25− and CD4+CD25+ T cell fractions, we found
that these cells were generated more efficiently from the total un-
fractionated CD4+ T cells (Figure 1C). It is possible that the
interactions between CD4+CD25− and CD4+CD25+ cells are
helpful for the optimal induction of CD25hiTNFR2+ T cells under
physiological conditions.
These induced CD25hiTNFR2+ T cells (regardless of the start-
ing population) had a typical Treg phenotype: significantly higher
levels of FOXP3, CTLA4, and lower levels of CD127, when com-
pared to the CD25−TNFR2− and CD25intTNFR2int/− cells within
the same culture. Figure 1D is a representative phenotype of
CD25hiTNFR2+ T cells induced from CD4+CD25+ T cell popu-
lation. Figure 1E represents the quantitative analysis for FOXP3
expression on the induced TNFR2 subsets. The induced TNFR2+
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FIGURE 1 | Phenotype of inducedTNFR2+ T cells. (A)The expression of
CD25 and TNFR2 on MACS sorted CD4+CD25− T cells and CD4+CD25+
cells after 72 h of CD3/28 stimulation. (B)The expression of FOXP3 on
TNFR2 subsets induced from starting population CD4+CD25+ T cells. (C)
Comparison of percentages of CD25hiTNFR2+ T cells induced from the
different starting populations – the CD4+CD25−, CD4+CD25+, or
un-fractionated CD4+ T cells. (D) Expression of regulatory molecules on
TNFR2 subsets from starting population CD4+CD25+ T cells. Gray
histograms represent isotype staining while clear histogram represents
the indicated molecule. The numbers indicate percentage positive for the
represented molecular marker. (E)The MFI of FOXP3 within the TNFR2
subsets. (F)The mRNA expression levels of FOXP3 within the TNFR2
subsets. Data shown in (A,B,D) are representative of four donors
respectively while (C,E,F) are summarized from four donors.
Kruskal–Wallis with Dunn’s multiple comparison test was used here and
graphs represent mean±SEM. *p<0.05.
T cell subset had the highest level of FOXP3 expression when
compared to the other TNFR2int/− T cell subsets, as shown in
both Figures 1B,D. This was further confirmed at the mRNA
level using qPCR (Figure 1F). As the phenotype of the induced
CD25hiTNFR2+ T cells contained similar percentage of cells posi-
tive for CTLA4 and FOXP3 (see Figure A1 in Appendix) across
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all starting populations (CD4+CD25−, CD4+CD25+, or un-
fractioned CD4+ T cells), in the following sections we used the
un-fractioned CD4 T cells as starting population.
As conventional effector human T cells also express low lev-
els of FOXP3, it was important to confirm that the in vitro
CD25hiTNFR2+ T cells had the highest level of FOXP3 expression.
We compared FOXP3 levels between the induced CD25hiTNFR2+
T cells and ex vivo Tregs (Figure 2). Firstly, consistent with pre-
vious studies, we observed that ex vivo Tregs expressing TNFR2
had the higher levels of FOXP3 when compared to TNFR2−
Tregs (Figure 2A). Moreover, induced CD25hiTNFR2+ T cells
had significantly higher levels of FOXP3 when compared to ex
vivo TNFR2+ Tregs (Figure 2B). Similar results were obtained
even when FOXP3 MFI levels were normalized to the corre-
sponding CD25−TNFR2− cells for each donor to avoid any
experimental variations and then compared between induced
CD25hiTNFR2+ T cells and ex vivo TNFR2+ Tregs (Figure A2
in Appendix).
Collectively, our data suggests that induced CD25hiTNFR2+ T
cells have a regulatory T cell phenotype and their FOXP3 levels are
significantly higher than that of ex vivo Tregs.
IN VITRO INDUCED CD25HITNFR2+ T CELLS DO NOT SUPPRESS
PROLIFERATIVE T CELL RESPONSES
Since the induced CD25hiTNFR2+ T cells displayed a typical
regulatory T cell phenotype, they would be expected to have
regulatory function. Inhibition of proliferative T cell responses
is a well-studied suppressor function attributed to Tregs. The
CD25hiTNFR2+ and CD25intTNFR2int/− cells were isolated using
flow cytometry on day 3 from the CD4 T cell starting culture, irra-
diated,and added at 1:1 ratio to responders,which were autologous
CD4+ T cells. Surprisingly, the induced CD25hiTNFR2+ T cells
did not suppress responder T cell proliferation, but instead, were
found to enhance it (Figure 3A). Chen and colleagues demon-
strated freshly isolated CD25+TNFR2+ T cells suppress T cell pro-
liferation in assays that further contain added antigen presenting
FIGURE 2 | FOXP3 expression levels on ex vivo and inducedTNFR2+ T
cells. Flow cytometry was performed on both ex vivo PBMCs (N =14) and
in vitro induced T cells (N =4). These cells were initially gated on CD3,
CD4, CD25, and TNFR2 expression to identify the different TNFR2
populations, noting that the CD25/TNFR2 phenotype was considerably
different between fresh and cultured cells. (A) FOXP3 expression was
further compared between CD25−TNFR2− (tinted histogram),
CD25intTNFR2int/− (thin clear histogram), and CD25hiTNFR2+ (thick clear
histogram). (B)The FOXP3 expression levels were compared between ex
vivo CD25hiTNFR2+ and induced CD25hiTNFR2+ T cells. Unpaired Student’s
t -test was performed to compare FOXP3 levels and graphs represent
mean±SEM. ****p<0.0001.
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cells (APCs) (12). We therefore also performed the above sup-
pression assays with the further addition of autologous APCs, to
account for any potential indirect suppressor TNFR2+ Treg effects.
As shown in Figure 3B, the induced CD25hiTNFR2+ T cells again
failed to suppress under these conditions. We speculated that the
strong signaling of responder cells by CD3/28 cross linking may
not be capable of being suppressed by CD25hiTNFR2+ Tregs, but
other, more natural T cell stimulation protocols could be suscep-
tible to suppression. The MLR where T cells from donors with
different MHC react to each other is a biologically relevant assay
(18). We found that induced CD25hiTNFR2+ T cells were not
capable of suppressing MLRs, and instead the addition of these
cells into MLR cultures further enhanced proliferative responses
(Figure 3C). Therefore, three different independent suppression
assays indicated that in vitro induced CD25hiTNFR2+ T cells from
healthy CD4 T cells do not have conventional suppressor function.
INDUCED CD25HITNFR2+ T CELLS PRODUCE EFFECTOR CYTOKINES IL-2
AND IFN-G AND ARE HYPER-PROLIFERATIVE
To further analyze the function of induced CD25hiTNFR2+ T cells,
we assessed their proliferative capacity. As shown in Figure 4A,
induced CD25hiTNFR2+ T cells had a significantly higher pro-
liferative capacity compared to the TNFR2− T cells when re-
stimulated with CD3/28 cross linking. Analyzing the cytokine
production capacity of the sorted CD25hiTNFR2+ T cells, we
found that intracellular IL-2 production in TNFR2+ cells were
significantly higher compared to the TNFR2− or TNFR2int/− sub-
sets (Figure 4B), suggesting a mechanism underlying both their
increased proliferative capacity and ability to enhance effector T
cell proliferation. The CD25hiTNFR2+ T cells also secreted sig-
nificantly higher levels of IFN-g into the supernatant compared
to the TNFR2− or TNFR2int/− subsets (Figure 4D), and interest-
ingly, they also secreted IL-10, while the TNFR2int/− and TNFR2−
cells did not secrete this cytokine (Figure 4C). IL-10 secretion,
however, was present at a much lower concentration when com-
pared to IFN-g and clearly insufficient to suppress proliferative
responses. The phenotype of the induced CD25hiTNFR2+ T cells
was further confirmed by mRNA expression level, determined
using qPCR. Compared to TNFR2int/− and TNFR2− cells, the
in vitro induced CD25hiTNFR2+ T cells expressed significantly
higher mRNA level for IFN-g, IL-10 and the Th1 transcription
factor, T-bet (Figures 4C,D). We also analyzed intracellular IFN-g
production by these different induced TNFR2 populations from
total PBMCs. Consistent with the mRNA levels and the cytokine
levels present in the supernatant, we observed that the induced
CD25hiTNFR2+ T cells have the highest intracellular production
of IFN-g compared to the other induced populations, TNFR2−
and TNFR2int/− T cells (Figure 4E).
DISCUSSION
In contrast to studies demonstrating effector T cells acquire only
low levels of FOXP3 upon activation (8, 19), we find that induced
CD25hiTNFR2+ T cells in vitro from CD4 T cells express high
levels of FOXP3. Moreover, although it has been accepted as dogma
that FOXP3 expression turns off IFN-g production (7, 8, 20), our
results suggest that upon T cell activation, CD25hiTNFR2+ express
not only IFN-g but also IL-2, IL-10, T-bet and thus these T cells
FIGURE 3 | Suppressive capacity of inducedTNFR2+ T cells. CD4+ T cells
were stimulated with anti-CD3/28 for 72 h. On day 3, induced
CD25intTNFR2int/− and CD25hiTNFR2+ were sorted by flow cytometry and
added to autologous responders (CD4+ T cells) at a ratio of 1:1 and
stimulated with anti-CD3/28 for 72 h in the (A) absence of APCs or (B)
presence of APCs. (C) Suppression assays performed using MLRs as
responders. PBMCs of three different donors were isolated and cultured
together with the indicated TNFR2 subsets at a 1:1 ratio. One-way ANOVA
with Tukey’s multiple comparison test was used for (A,C), and
Kruskal–Wallis with Dunn’s multiple comparison test was used for (B). Error
bars indicate SD for (A,B) and SEM for (C). Comparison of the proliferation
of responders: *p<0.05; ***p< 0.001.
identify a maximally active cytokine-producing subset. Although
several studies have demonstrated that TNFR2 can be up-regulated
on murine and human T cells upon activation (17, 21, 22), our
study is the first to demonstrate that TNFR2 expression on human
CD4+ T cells is concomitantly up-regulated with FOXP3 upon
polyclonal TCR stimulation.
Despite high FOXP3 expression, which is a master regulatory
gene enabling suppressive cell function (23), the role of induced
CD25hiTNFR2+FOXP3+ T cells in the immune system may not
necessarily be immune-suppressive. It is possible that the induced
CD25hiTNFR2+ subset is a heterogeneous population containing
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FIGURE 4 | Proliferative capacity, IL-2, and IFN-g production by induced
CD25hiTNFR2+ T cells. (A)The proliferative capacity of sorted TNFR2 subsets
(originated from the un-fractionated CD4+ cells) upon 72 h anti-CD3/28
re-stimulation. N =6. (B) Intracellular expression of IL-2 (upper panel, N =2)
by the sorted cells. (C) IL-10 secreted into the supernatant during the
re-stimulation of the sorted TNFR2 subsets (N =4) was determined using
CBA-flex kits (left panel) and IL-10 mRNA levels (right panel) was determined
using qPCR (N =4). (D) IFN-g secreted into the supernatant during the
re-stimulation of the sorted TNFR2 subsets (N =4) (left panel) and the mRNA
expression levels of IFN-g and T-bet on sorted TNFR2 subsets (N =4) (right
panel). (E)Total PBMCs were stimulated using CD3/28 to obtain the induced
TNFR2 populations. On day 3, cells were further stimulated with
PMA/Ionomycin in the presence of Brefeldin A to determine intracellular IFN-g
production. Flow cytometry was performed to identify the different induced
TNFR2 populations and their IFN-g production was determined. Data is
representative of four donors. Kruskal–Wallis with Dunn’s multiple
comparison test was used and error bars indicate SEM. Comparison of
proliferation, mRNA and cytokine levels: *p<0.05; **p< 0.01; ***p<0.001.
both effector and Tregs, however we have demonstrated here that
the effector T cells clearly dominate in function in this induced
subset. Moreover, the plasticity among T cells is a well-established
phenomenon (24, 25) and hence it is not accurate to distinguish
cells based merely on their phenotype without considering the
nature of their induction.
Our findings may seem to be contradictory to previous studies,
which demonstrate that freshly isolated CD25+TNFR2+ T cells
that express high levels of FOXP3 were maximally suppressive
(10, 12). We do not believe a lack of suppression in the induced
CD25hiTNFR2+ population was due to the difference in the sup-
pression assay protocol employed as we have also demonstrated
that ex vivo Tregs (both TNFR2+ and TNFR2− Treg subsets) are
capable of suppressing responder T cell proliferation (Figure A3
in Appendix). However, this disparity in function between ex vivo
and induced cells with a similar phenotype may be explained by
the history of the cells, for instance, there could be functional
differences between freshly isolated cells obtained from a bal-
anced immune micro-environment and induced cells obtained
as a result of polyclonal TCR stimulation of CD4 T cells. The
potential plasticity of T cells, or how they may change pheno-
type and/or function in response to microenvironments, implies
that the types of stimuli or culture conditions play a role in
the phenotype or function of the induced T cells. We demon-
strate here that in vitro stimulation of T cells with anti-CD3 and
anti-CD28 results in several populations with varying effector
functions, but none of the induced populations were suppressive
in function.
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Our results together with previous studies indicate that whereas
freshly isolated peripheral blood CD25+/hiTNFR2+ T cells help
maintain homeostasis, by preventing the activation of self-reactive
cells in the absence of an active immune response, or after anti-
gen clearance, induced CD25hiTNFR2+ T cells generated rapidly
from circulating precursors by TCR stimulation in the absence of
micro-environmental signals, would by contrast play a pivotal role
in initiating responses against potential pathogens by maximally
producing effector cytokines.
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APPENDIX
FIGUREA1 | Phenotype of inducedTNFR2+ T cells from CD4+CD25− T
cell, CD4+CD25+ T cells, and un-fractionated CD4+ cells. Expression of
regulatory molecules on TNFR2 subsets from starting population
CD4+CD25− T cells, CD4+CD25+ T cells, and un-fractionated CD4+ T cells.
Gray histograms represent isotype staining while clear histogram
represents the indicated molecule. The numbers indicate percentage
positive for the represented molecular marker.
FIGUREA2 | FOXP3 expression levels on ex vivo and inducedTNFR2+ T
cells. The FOXP3 expression levels were compared between ex vivo
CD25hiTNFR2+ and induced CD25hiTNFR2+ T cells. Unpaired Student’s
t -test was performed to compare FOXP3 levels and graphs represent
mean±SEM. **p<0.01.
FIGUREA3 | Suppression assays performed using ex vivoTregs from
healthy donors. PBMCs from healthy donors were stained with Treg
markers, CD4, CD25, and TNFR2 to sort for non-induced ex vivo Tregs. Tregs
were identified as either CD4+CD25hiTNFR2+ T cells or CD4+CD25hiTNFR2−
T cells. The sorted Tregs were added to autologous responders (CD4+ T cells)
at a ratio of 1:1 and stimulated with anti-CD3/28 for 72 h in 96 well plates.
(A) Represents a suppression assay using CD25hiTNFR2+ T cells as the Treg
population while (B) Represents a suppression assay using CD25hiTNFR2−
T cells as the Treg population. Data shown here represents mean±SD.
Unpaired t -tests was used to determine statistical significance. *p<0.05.
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